The world economy is losing five hundred billion dollars every month do ta cobet. That means that it's worth investing a lot in trying to develop at vacine, even though there's a pretty high risk of failure. The private returns from building out a very large factory for vaccine before we know whether the vaccine is going to work are much less than the social returns. You probably want toa mix of push incentives and pull incentives, some reward for success, but also just upfront financing for building those factories ahead of time....
Michael Kremer is best known for his academic work researching global poverty, for which he was awarded the Nobel Prize in 2019 along with Esther Duflo and Abhijit Banerjee. Less known is that he is also the founder of five non-profits and in the process of creating a sixth. And Kremer doesn’t see anything unusual about embodying the dual archetypes of economist and founder. “I think there's a lot of relationship between the experimental method and the things that are needed to help found organizations,” he explains.
Michael joined Tyler to discuss the intellectual challenge of founding organizations, applying methods from behavioral economics to design better programs, how advanced market commitments could lower pharmaceutical costs for consumers while still incentivizing R&D, the ongoing cycle of experimentation every innovator understands, the political economy of public health initiatives, the importance of designing institutions to increase technological change, the production function of new technologies, incentivizing educational achievement, The Odyssey as a tale of comparative development, why he recently transitioned to University of Chicago, what researchers can learn from venture capitalists, his current work addressing COVID-19, and more.
Read a full transcript enhanced with helpful links, or watch the full video.
Recorded September 9th, 2020 Other ways to connect